-+ 0.00%
-+ 0.00%
-+ 0.00%

Veraxa Biotech Director Christoph Samuel Ziegler Reports $32,700 Common Share Acquisition

PUBT·10/21/2026 20:11:06
Listen to the news
Veraxa Biotech Director Christoph Samuel Ziegler Reports $32,700 Common Share Acquisition
  • Veraxa Biotech director Christoph Samuel Ziegler purchased 30,000 ordinary shares at $1.09 each.
  • His direct holdings rose to 37,932 ordinary shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veraxa Biotech AG published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-26-011387), on October 21, 2026, and is solely responsible for the information contained therein.